Position in GMAB
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$6,013,783
-$1,188,858 QoQ
Shares Held
224,144
-4.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $266,175,967 across 93 Biotechnology names. GMAB ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,388,920 | $145,350,778 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,954 | $26,771,859 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
166,617 | $10,768,456 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,316 | $9,515,834 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
29,569 | $8,781,105 | |
| 6 | ARGX |
Argenx SE
|
9,275 | $6,773,068 | |
| 7 | GMAB |
Genmab A/S
This page
|
224,144 | $6,013,783 | |
| 8 | INSM |
INSMED Inc
|
34,258 | $5,601,868 |
All Filings in GMAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,013,783 | 224,144 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,202,641 | 233,852 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $284,188 | 9,266 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,462 | 216 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,268 | 218 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $377,934 | 18,109 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,014,495 | 82,629 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,786,994 | 71,110 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,950,879 | 65,225 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,385,613 | 43,518 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,441,908 | 40,882 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,401,086 | 36,861 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,106,556 | 29,305 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,058,949 | 24,987 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $814,752 | 25,358 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $629,168 | 19,365 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $458,545 | 12,674 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $335,508 | 8,481 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,099,959 | 48,054 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,788,354 | 43,800 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $961,065 | 29,274 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,091,639 | 26,848 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $675,930 | 18,463 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $107,126 | 3,161 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $85,226 | 4,022 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||